Cargando…

Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial

PURPOSE: To evaluate the relationship between duration of macular edema associated with retinal vein occlusion (RVO) and the achievement of vision gain in patients receiving dexamethasone intravitreal implant (DEX implant) in real-world clinical practice, and to define patterns of use of DEX implant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eter, Nicole, Mohr, Andreas, Wachtlin, Joachim, Feltgen, Nicolas, Shirlaw, Andrew, Leaback, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Retinal Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203822/ https://www.ncbi.nlm.nih.gov/pubmed/27460280 http://dx.doi.org/10.1007/s00417-016-3431-x

Ejemplares similares

Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
por: Korobelnik, Jean-François, et al.
Publicado: (2016)

Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
por: Li, Xiaoxin, et al.
Publicado: (2017)

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)

Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
por: de Salles, Manuel Casselholm, et al.
Publicado: (2021)

Importance of continuous treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration—12-month post hoc analysis of the PERSEUS real-world evidence study
por: Wachtlin, Joachim, et al.
Publicado: (2020)

PERSEUS 24-month analysis: a prospective non-interventional study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Germany in patients with neovascular age-related macular degeneration
por: Eter, Nicole, et al.
Publicado: (2021)

Long-term outcomes of intravitreal activated protein C injection for ischemic central retinal vein occlusion: an extension trial
por: Hara, Chikako, et al.
Publicado: (2021)

Disease-modifying effects of ranibizumab for central retinal vein occlusion
por: Huang, Jason M., et al.
Publicado: (2021)

Posterior vitreous detachment following intravitreal drug injection
por: Geck, Ulrich, et al.
Publicado: (2013)

Evaluation of non-exudative microcystoid macular abnormalities secondary to retinal vein occlusion
por: Francone, Anibal, et al.
Publicado: (2021)

The usefulness of the retinal sensitivity measurement with a microperimetry for predicting the visual prognosis of branch retinal vein occlusion with macular edema
por: Fujino, Ryosuke, et al.
Publicado: (2020)

Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
por: Kida, Teruyo, et al.
Publicado: (2021)

Rhegmatogenous retinal detachment following intravitreal ocriplasmin
por: Madi, Haifa A., et al.
Publicado: (2016)

Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion
por: Fortunato, Pina, et al.
Publicado: (2009)

Intravitreal dexamethasone: variation of surgical technique and prevention of ocular complications with ASOCT follow-up
por: Nuzzi, Raffaele, et al.
Publicado: (2022)

Postponed care due to COVID-19 lockdown impact on visual acuity of retinal vein occlusion patients: a large cohort
por: Cohen, Ram, et al.
Publicado: (2022)

Intravitreal injection associated rhegmatogenous retinal detachment: outcomes of a European analysis
por: Vounotrypidis, Efstathios, et al.
Publicado: (2021)

A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusion
por: Bandello, Francesco, et al.
Publicado: (2018)

Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography
por: Clemens, C. R., et al.
Publicado: (2020)

Retinal vascular occlusion and SARS-CoV-2 vaccination
por: Vujosevic, Stela, et al.
Publicado: (2022)

Correlation between change in central subfield thickness and change in visual acuity in macular edema due to retinal vein occlusion: post hoc analysis of COPERNICUS, GALILEO, and VIBRANT
por: Gu, Sophie Z., et al.
Publicado: (2022)

Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
por: Sugimoto, Masahiko, et al.
Publicado: (2022)

The detrimental effects of delayed intravitreal anti-VEGF therapy for treating retinal pathology: lessons from a forced test-case
por: Navarrete, Ana, et al.
Publicado: (2022)

Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
por: Zirpel, Johanna J., et al.
Publicado: (2021)

See clearer: survey on the subjective and objective information levels as well as perception and information transfer using virtual reality headsets in patients with diabetic macular edema receiving anti-VEGF treatment
por: Enders, Christian, et al.
Publicado: (2022)

The effect of a preoperative subconjuntival injection of dexamethasone on blood–retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial
por: Bali, Ernesto, et al.
Publicado: (2010)

Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye
por: Sugimoto, Masahiko, et al.
Publicado: (2017)

Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration
por: Cohen, Salomon-Yves, et al.
Publicado: (2022)

Treatment contentment and preference of patients undergoing intravitreal anti-VEGF therapy
por: Kellner, Ulrich, et al.
Publicado: (2021)

Impact of intravitreal injection therapy on contrast sensitivity in patients with nAMD and DME
por: Dieke, Sebastian, et al.
Publicado: (2023)

Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study
por: Ohji, Masahito, et al.
Publicado: (2021)

Legal obligation in the general population: face mask influence on endophthalmitis after intravitreal injection
por: Neubauer, Jonas, et al.
Publicado: (2022)

Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
por: Hanhart, Joel, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic’s first wave on the care and treatment situation of intravitreal injections in a German metropolitan region
por: Stemplewitz, Birthe, et al.
Publicado: (2022)

Ciliary body length revisited by anterior segment optical coherence tomography: implications for safe access to the pars plana for intravitreal injections
por: Lincke, Joel-Benjamin, et al.
Publicado: (2020)

Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
por: Liu, Siyin, et al.
Publicado: (2022)

Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting
por: Granstam, Elisabet, et al.
Publicado: (2021)

Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect”
por: Borrelli, Enrico, et al.
Publicado: (2020)

Analysis of imaging biomarkers and retinal nerve fiber layer thickness in RPGR-associated retinitis pigmentosa
por: Birtel, Theresa H., et al.
Publicado: (2021)

The learning curve of retinal detachment surgery
por: Radeck, Viola, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q2dk0gh8tb1ldv1kh8n8f9jcal